Cost-effectiveness of the implementation of [(68)Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging

BACKGROUND: Despite its high specificity, PSMA PET/CT has a moderate to low sensitivity of 40–50% for pelvic lymph node detection, implicating that a negative PSMA PET/CT cannot rule out lymph node metastases. This study investigates a strategy of implementing PSMA PET/CT for initial prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Sar, Esmée C. A., Keusters, Willem R., van Kalmthout, Ludwike W. M., Braat, Arthur J. A. T., de Keizer, Bart, Frederix, Geert W. J., Kooistra, Anko, Lavalaye, Jules, Lam, Marnix G. E. H., van Melick, Harm H. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375809/
https://www.ncbi.nlm.nih.gov/pubmed/35962838
http://dx.doi.org/10.1186/s13244-022-01265-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375809/
https://www.ncbi.nlm.nih.gov/pubmed/35962838
http://dx.doi.org/10.1186/s13244-022-01265-w

Ejemplares similares